Figure 3.
Effects of terminal ileum mucosal supernatant from the control group (A) and the post-infectious irritable bowel syndrome (PI-IBS) group (B), and effects of ileum mucosal supernatant from the PI-IBS group pretreated with Nasmil (C) on mesenteric nerve firing. (D) Discharge frequency of mesenteric nerves at baseline and after perfusion of ileum mucosal supernatant from control, PI-IBS, and PI-IBS + Nasmil groups.
